Ruplizumab
Ruplizumab (BG 9588), a humanized monoclonal IgG1κ antibody targeting CD40L (TNF Receptor), holds promise for research in systemic lupus erythematosus disease .
Product Specifications
CAS Number
220651-94-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
37935111 3x 1.0 µg
PSMA1 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
LS001670-100ug 100 µg
Alpha 5 Defensin (DEFA5) (NM_021010) Human Over-expression Lysate
Sign In for Pricing
View Details 
ICH1084-25mg 25 mg
Anti-CTLA-4 (9H10) In Vivo Antibody - Low Endotoxin
Sign In for Pricing
View Details M2825-15F-ML750 100 µL
MDR1 (Multi Drug Resistance Protein 1, ABC20, ATP Binding Cassette Subfamily B (MDR/TAP) Member 1, ABCB1, CD243, CLCS, GP170, P-Glycoprotein, P-gp, P Glycoprotein 1, PGY1) (MaxLight 750) discontinued
Sign In for Pricing
View Details